AKT1 and cancer: Additionally, this drug has been demonstrated to regulate important cellular dynamics particularly during cancer progression (i.e., modulation of PI3K/Akt/mTOR activity) while promoting normal brain health through induction of BDNF (Van Kanegan et al., 2014; Pan et al., 2015).